Reappraisal of MMR vaccines currently used in Korea.

@article{Lee2011ReappraisalOM,
  title={Reappraisal of MMR vaccines currently used in Korea.},
  author={Hyunju Lee and Han Wool Kim and Hye Kyung Cho and Eun Ae Park and Kyong Min Choi and Kyung Hyo Kim},
  journal={Pediatrics international : official journal of the Japan Pediatric Society},
  year={2011},
  volume={53 3},
  pages={374-80}
}
BACKGROUND Although MMR vaccine is widely used in Korea, there are limited studies on the currently used vaccines. We evaluated the immunogenicity and safety of MMR vaccines in Korean children. METHODS For first and second dose immunization, children aged 12-23 months and 4-6 years were enrolled. All subjects received a single dose of either Priorix™ (Glaxo Smithkline Biologicals, Rixensart, Belgium) or MMRII® (Merck & Co., Inc., West Point, PA, USA). Pre- and postvaccine sera were collected… CONTINUE READING

From This Paper

Topics from this paper.

Similar Papers

Loading similar papers…